• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Moleculer mechanism of Hepatocarcinogenesis and Development : Combined Analysis with Kupffer phase Contrast-enchanced US and Gene Expression.

Research Project

Project/Area Number 23650312
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Medical systems
Research InstitutionKinki University

Principal Investigator

KUDO Masatoshi  近畿大学, 医学部, 教授 (10298953)

Co-Investigator(Kenkyū-buntansha) INOUE Tatsuo  近畿大学, 医学部, 講師 (20441024)
Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords超音波医科学 / ソナゾイド造影超音波 / 肝細胞癌 / クッパー細胞 / 遺伝子多型
Research Abstract

OATP8 epression is observed in dysplastic nodule, but not in early hepatocellular carcinoma (e-HCC),which is shown as low intense on kupffer phase contrast-enhanced US. In addition,Glypican3,HSP70,GS,CAP2,Bmi-1 are highly expressed in e-HCC during multistep hepatocarcinogenesis.

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Research-status Report
  • Research Products

    (117 results)

All 2012 2011

All Journal Article (54 results) (of which Peer Reviewed: 54 results) Presentation (63 results) (of which Invited: 13 results)

  • [Journal Article] Quantification of tumor vascularity with contrast-enhanced ultrasound for early response of transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of three cases.2012

    • Author(s)
      Minami Y, Okumura N, Yamamoto N, Tsuji N, Kono Y, Kudo M
    • Journal Title

      J Med Ultrason

      Volume: 28 Pages: 15-19

    • NAID

      10030380257

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.2012

    • Author(s)
      Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A, Abecassis M, Balabaud C, Barritt GJ, Belghiti J, Bhoori S, Bossuyt P, Breitenstein S, Broelsch C, Bruix J, Burra P, Burroughs A, Busuttil R,Charlton M, Cherqui D, Colombo ML, d'Albuquerque C, D'Alessandro A, de Santibanez EJ, Dufour F, Durand F, Dutkowski P, Duvoux C, El-Serag H, Fan ST, Finn RS, Fisher R, Forner A, Freeman R, Fung J, Geier A, Germani G, Gores G, Gouw AS, Grant D, Greig P, Gurusamy K, Hanto D, Heaton N, Heim M, Hemming A, Hippen B, Hisham A, Hubscher S, Ichida T, Kahn D, Kew M, Kita Y, Kiuchi T, Klintmalm GB, Kneteman N, Kojiro M, Kudo M, Langer B, Lee JM, Lee SG, Lencioni R, Lerut J, Lesurtel M, Livraghi T, Llovet JM, Lo CM, Lodge P, MacCaughan G, Madoff D, Majno P, Marcellin P, Marrero J, Mazzaferro V, Mergental H, Merle P, Miksad R, Mornex F, Mullhaupt B, Olthoff K, Paradis V, Perrier A, Pestalozzi B, Pomfret E, Poon R, Porte R, Greig P, Prasad KR, Raptis D, Roskams T, Rossi M, Samuel D, Schlitt H, Schwartz M, Sexton Dobby AM, Shaked A, Sherman M, Siegler M, Suh KS, Todo S, Toso C, Trevisani F, Trotter JJ, Veldecasas GJ, Vauthey N, Vilgrain V, Villamil F, Vonlanthen R, Wald C, Weber A, Wiesner R, Wright L, Yao F, Zheng SS, Zucman-Rossi J
    • Journal Title

      Lancet Oncol

      Volume: 13

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: Usefulness of virtual CT sonography with magnetic navigation.2012

    • Author(s)
      Minami Y, Kitai S, Kudo M
    • Journal Title

      Eur J Radiol

      Volume: 81

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.2012

    • Author(s)
      Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M
    • Journal Title

      J Hepatol

      Volume: 56 Pages: 886-892

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Current status of hepatocellular carcinoma treatment in Japan: Case study and discussion-voting system2012

    • Author(s)
      Kudo M, Tateishi R, Yamashita T, Ikeda M, Furuse J, Ikeda K, Kokudo N, Izumi N, Matsui O
    • Journal Title

      Clin Drug Invest

      Volume: 32;suppl.2 Pages: 37-51

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Well-differentiated hepatocellular carcinoma detected as hypovascularity by only CT during hepatic arteriography.2012

    • Author(s)
      Saito J, Kim SR, Kuod M, Imoto S, Ando K, Nakajima T, Fukuda K, Otono Y, Kim SK, Komaki T, Yano H, Nakashima O, Sugimoto K, Matsuoka T
    • Journal Title

      Intern Med

      Volume: 51 Pages: 885-890

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study.2012

    • Author(s)
      Lencioni R, Kudo M, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Guevara LL, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Cihon F, Heldner S, Marrero JA
    • Journal Title

      Int J Clin Pract

      Volume: 66 Pages: 675-683

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function ?2012

    • Author(s)
      Okada M, Ishii K, Numata K, Hyodo T, Kumano S, Kitano M, Kudo M, Murakami T
    • Journal Title

      Hepatob Pancreatic Dis Int

      Volume: 11 Pages: 307-313

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Activation of JNK and high expression level of CD133 predict a poor response to Sorafenib in hepatocellular carcinoma.2012

    • Author(s)
      Hagiwara S, Kudo M, Nagai T, Inoue T, Ueshima K, Nishida N, Watanabe T, Sakurai T
    • Journal Title

      Brit J Cancer

      Volume: 106 Pages: 1997-2003

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Mechanical model analysis for quantitative evaluation of liver fibrosis based on ultrasound tissue elasticity imaging.2012

    • Author(s)
      Shiina T, Maki T, Yamakawa M, Mitake T, Kudo M, Fujimoto K
    • Journal Title

      Jpn J Appl Phys

      Volume: 51

    • NAID

      210000140983

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Characteristic pattern of reactivation of hepatitis B virus during chemotherapy for solid cancers.2012

    • Author(s)
      agiwara S, Sakurai T, Nishina S, Tanaka K, Ikeda M, Ueshima K, Minami Y, Inoue T, Yada N, Kitai S, Takita M, Nagai T, Hayaishi S, Arizumi T, Park AM, Munakata H, Nishida N, Kudo M
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 541-546

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Gender differences in the livers of patients with hepatocellular carcinoma and chronic hepatitis C infection.2012

    • Author(s)
      ishida N, Arizumi T, Hayaishi S, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Ikai I, Kudo M
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 547-553

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Retreatment with peginterferon alfa-2a plus ribavirin in patients who failed previous peginterferon alfa-2b plus ribavirin combination therapy.2012

    • Author(s)
      Ueda T, Tsuchiya K, Hashimoto S, Inoue T, Inao M, Tanaka A, Kaito M, Imazaki F, Nishiguchi S, Mochida S, Yokosuka O, Yatsuhashi H, Izumi N, Kudo M, for RETRY study group:
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 554-560

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Risk of HCC development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα2a2012

    • Author(s)
      Hagiwara S, Sakurai T, Takita M, Ueshima K, Minami Y, Inoue T, Yada N, Kitai S, Nagai T, Hayaishi S, Arizumi T, Nishida N, Kudo M
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 561-567

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Histopathological diagnosis of early HCC through biopsy -efficacy of victoria blue and cytokeratin 7 staining-2012

    • Author(s)
      Kobayashi S, Kim SR, Imoto S, Ando K, Hirakawa M, Saito J, Fukuda K, Otono Y, Sakaki M, Tsuchida S, Kim SK, Hayashi Y, Nakano M, Kudo M
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 574-579

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] ovel non-trocar technique for laparoscopic radiofrequency ablation.2012

    • Author(s)
      Tsuchida S, Fukumoto T, Toyokawa A, Awazu M, Kusunoki N, Kido M, Takahashi M, Tanaka M, Kuramitsu K, Kim SR, Kudo M, Ku Y
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 588-591

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.2012

    • Author(s)
      Minami Y, Kudo M
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 592-597

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Real-life clinical practice with sorafenib in advanced hepatocellular carcinoma: a aingle center experience.2012

    • Author(s)
      Kudo M, Ueshima K, Arizumi T
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 609-616

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging.2012

    • Author(s)
      Katsube T, Okada M, Kumano S, Imaoka I, Kagawa Y, Hori M, Ishii K, Tanigawa N, Imai Y, Kudo M, Murakami T
    • Journal Title

      Eur J Radiol

      Volume: 81 Pages: 1460-1464

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma.2012

    • Author(s)
      Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A
    • Journal Title

      Hepatology

      Volume: 56 Pages: 994-1003

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma.2012

    • Author(s)
      Kudo M
    • Journal Title

      World J Gastroenterol

      Volume: 18 Pages: 6005-6017

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] apan's successful model of nationwide hepatocellular carcinoma surveillance highlighting the urgent need for global surveillance.2012

    • Author(s)
      Kudo M
    • Journal Title

      Liver Cancer

      Volume: 1(3) Pages: 141-143

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma.2012

    • Author(s)
      Okusaka T, Kasugai H, Ishii H, Kudo M, Sata M, Tanaka K, Shioyama Y, Chayama K, Kumada H, Yoshikawa M, Seki T, Saito H, Hayashi N, Shiratori K, Okita K, Sakaida I, Honda M, Kusumoto Y, Tsutsumi T, Sakata K
    • Journal Title

      Invest New Drug

      Volume: 30 Pages: 2015-2025

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma.2012

    • Author(s)
      Hagiwara S, Kudo M, Chung H, Ueshima K, Inoue T, Haji S, Watanabe T, Park AM, Munakata H, Sakurai T
    • Journal Title

      Hepatol Res

      Volume: 42 Pages: 394-400

    • NAID

      10031144252

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Targeted therapy for liver cancer: updated review in 2012.2012

    • Author(s)
      Kudo M
    • Journal Title

      Curr Cancer Drug Tar

      Volume: 12 Pages: 1062-1072

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Guideline on the use of new anticancer drugs for the treatment of hepatocellular carcinoma 2010 update.2012

    • Author(s)
      Kaneko S, Furuse J, Kudo M, Ikeda K, Honda M, Nakamoto Y, Onchi M, Shiota G, Yokosuka O, Sakaida I, Takehara T, Ueno Y, Hiroishi K, Nishiguchi S, Moriwaki H, Yamamoto K, Sata M, Obi S, Miyayama S, Imai Y
    • Journal Title

      Hepatol Res

      Volume: 42 Pages: 523-542

    • NAID

      10031144267

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Assessment of Gd-EOB-DTPA.enhanced MRI for HCC and Dysplastic nodule and comparison of detection sensitivity versus MDCT.2012

    • Author(s)
      Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami
    • Journal Title

      J Gastroenterol

      Volume: 47 Pages: 1036-1047

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.2012

    • Author(s)
      Clavien PA
    • Journal Title

      Lancet Oncol

      Volume: 13

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: Usefulness of virtual CT sonography with magnetic navigation.2012

    • Author(s)
      Minami Y
    • Journal Title

      Eur J Radiol

      Volume: 81

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Current status of hepatocellular carcinoma treatment in Japan: Case study and discussion-voting system.2012

    • Author(s)
      Kudo M
    • Journal Title

      Clin Drug Invest

      Volume: 32

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mechanical model analysis for quantitative evaluation of liver fibrosis based on ultrasound tissue elasticity imaging.2012

    • Author(s)
      Shiina T
    • Journal Title

      Jpn J Appl Phys

      Volume: 51

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Risk of HCC development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα2a.2012

    • Author(s)
      Hagiwara S
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 561-567

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Histopathological diagnosis of early HCC through biopsy -efficacy of victoria blue and cytokeratin 7 staining-.2012

    • Author(s)
      Kobayashi S
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 574-579

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Novel non-trocar technique for laparoscopic radiofrequency ablation.2012

    • Author(s)
      Tsuchida S
    • Journal Title

      Digest Dis

      Volume: 30 Pages: 588-591

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Japan's successful model of nationwide hepatocellular carcinoma surveillance highlighting the urgent need for global surveillance.2012

    • Author(s)
      Kudo M
    • Journal Title

      Liver Cancer

      Volume: 1(3) Pages: 141-143

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Assessment of Gd-EOB-DTPA–enhanced MRI for HCC and Dysplastic nodule and comparison of detection sensitivity versus MDCT.2012

    • Author(s)
      Inoue T
    • Journal Title

      J Gastroenterol

      Volume: 47 Pages: 1036-1047

    • NAID

      10031122091

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] orafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.2011

    • Author(s)
      Nagai T, Arao T, Furuta K, Sakai K, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Matsumoto K, Saijo N, Kudo M, Nishio K
    • Journal Title

      Mol Cancer Ther

      Volume: 10 Pages: 169-177

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Double-contrast ultrasoud: a novel surveillance tool for hepatocellular carcinoma.2011

    • Author(s)
      Kudo M, Hatanaka K, Kumada T, Toyoda H, Tada T
    • Journal Title

      Am J Gastroenterol

      Volume: 106 Pages: 368-370

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Antitumor activity of BIBF 1120, a vascular endothelial growth factor-2 inhibitor and use of VEGR2+pTYR+leucocyte as a pharmacodynamic biomarker.2011

    • Author(s)
      Kudo K, Arao T, Tanaka K, Kaneda H, Matsumoto K, Tamura D, Aomatsu K, Velasco M, Fujita Y, Saijo N, Kudo M, Nishio K
    • Journal Title

      Clin Cancer Res

      Volume: 17 Pages: 1373-1381

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] he cancer stem cell marker CD133 is a predictor of the effectiveness of S1+pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.2011

    • Author(s)
      Hagiwara S, Kudo M, Ueshima K, Chung H, Yamaguchi M, Takita M, Haji S, Kimura M, Arao T, Nishio K, Park AM, Munakata H
    • Journal Title

      J Gastroenterol

      Volume: 46 Pages: 212-221

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl -diethylenetriamine pentaacetic acid-enhanced MR.2011

    • Author(s)
      Kagawa Y, Okada M, Kumano S, Katsube T, Imaoka I, Tanigawa N, Ishii K, Kudo M, Murakami T
    • Journal Title

      J Magn Reson Imaging

      Volume: 33 Pages: 864-872

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Estimation of liver function using T1 mapping onGd-EOB-DTPA-enhanced magnetic resonance imaging.2011

    • Author(s)
      Katsube T, Okada M, Kumano S, Hori M, Imaoka I, Ishii K, Kudo M, Kitagaki H, Murakami T
    • Journal Title

      Invest Radiol

      Volume: 46 Pages: 277-283

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.2011

    • Author(s)
      Eguchi S, Kanematsu T, Arii S, Omata M, Kudo M, Sakamoto M, Takayasu K, Makuuchi M, Matsuyama Y, Monden M, for the Liver Cancer Study Group of Japan
    • Journal Title

      Brit J Surg

      Volume: 98 Pages: 552-557

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice guideline proposed by the Japan Society of Hepatology (JSH) 2010 updated version.2011

    • Author(s)
      Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M
    • Journal Title

      Digest Dis

      Volume: 29 Pages: 339-364

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.2011

    • Author(s)
      Yoshida H, Shiratori Y, Kudo M, Shiina S, Mizuta T, Kojiro M, Yamamoto K, Koike Y, Saito K, Koyanagi N, Kawabe T, Kawazoe S, Kobashi H, Kasugai H, Osaki Y, Araki Y, Izumi N, Oka H, Tsuiji K, Toyota J, Seki T, Osawa T, Masaki N, Ichinose M, Seike M, Ishikawa A, Ueno Y, Tagawa K, Kuromatsu R, Sakisaka S, Ikeda H, Kuroda H, Hokuryu H, Yamashita T, Sakaida I, Katamoto T, Kikuchi K, Nomoto M, Omata M
    • Journal Title

      Hepatology

      Volume: 54 Pages: 532-540

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Hepatocellular carcinoma in 2011 and beyond: From the pathogenesis to molecular targeted therapy.2011

    • Author(s)
      Kudo M
    • Journal Title

      Oncology

      Volume: 81 Pages: 1-10

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Signaling pathways governing tumor angiogenesis.2011

    • Author(s)
      Sakurai T, Kudo M
    • Journal Title

      Oncology

      Volume: 81 Pages: 24-29

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.2011

    • Author(s)
      Alaboudy A, Inoue T, Hatanak K, Chung H, Hyodo T, Kumano S, Murakami T, Moustafa EFA, Kudo M
    • Journal Title

      Oncology

      Volume: 81 Pages: 66-72

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Diagnostic imaging of hepatcocellular carcinoma: Recent progress.2011

    • Author(s)
      Kudo M
    • Journal Title

      Oncology

      Volume: 81 Pages: 73-85

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.2011

    • Author(s)
      Minami Y, Kudo M
    • Journal Title

      World J Gastroenterol

      Volume: 17 Pages: 4952-4959

    • Related Report
      2012 Final Research Report 2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.2011

    • Author(s)
      Nagai T
    • Journal Title

      Mol Cancer Ther

      Volume: 10 Pages: 169-177

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.2011

    • Author(s)
      Hagiwara S
    • Journal Title

      J Gastroenterol

      Volume: 46 Pages: 212-221

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl -diethylenetriamine pentaacetic acid-enhanced MR.2011

    • Author(s)
      Kagawa Y
    • Journal Title

      J Magn Reson Imaging

      Volume: 33 Pages: 864-872

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] stimation of liver function using T1 mapping onGd-EOB-DTPA-enhanced magnetic resonance imaging.2011

    • Author(s)
      Katsube T
    • Journal Title

      Invest Radiol

      Volume: 46 Pages: 277-283

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Presentation] Clinical findings in Child-pugh B score subgourps.2012

    • Author(s)
      Bronowicki JP
    • Organizer
      47th Annual Meeting of the European Association for the Sudy of the Liver (EASL)
    • Place of Presentation
      Barcelona,Spain
    • Related Report
      2012 Annual Research Report
  • [Presentation] Observed patterns of systemic therapy use in hepatocellular carcinoma (HCC) patients from the multinational HCC BRIDGE Study: Results of a second interim analysis.2012

    • Author(s)
      Colombo M
    • Organizer
      47th Annual Meeting of the European Association for the Sudy of the Liver (EASL)
    • Place of Presentation
      Barcelona,Spain
    • Related Report
      2012 Annual Research Report
  • [Presentation] Novel association between global DNA hypomethylation and chromosomal instability phenotype in human hepatocellular carcinoma.2012

    • Author(s)
      Nishida N
    • Organizer
      Digestive Disease Week(DDW) 2012
    • Place of Presentation
      San Diego,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Activation of JNK in the Non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma.2012

    • Author(s)
      Sakurai T
    • Organizer
      Digestive Disease Week(DDW) 2012
    • Place of Presentation
      San Diego,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] The decrease of blood flow after administration of sorafenib may improve overall survival in patients with advanced hepatocellular carcinoma.2012

    • Author(s)
      Arizumi T
    • Organizer
      Digestive Disease Week(DDW) 2012
    • Place of Presentation
      San Diego,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced sonography using perfluorocarbon microbubbles (sonazoid).2012

    • Author(s)
      Minami Y
    • Organizer
      Digestive Disease Week(DDW) 2012
    • Place of Presentation
      San Diego,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Usefulness of contrast-enhanced ultrasonography to evaluate a post treatment effect of radiofrequentry ablation about hepatocellular carcinoma: comparison with contrast-enhanced CT.2012

    • Author(s)
      Inoue T
    • Organizer
      Digestive Disease Week(DDW) 2012
    • Place of Presentation
      San Diego,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Phase 1b dose-escalation study of a phase 2 randomized trial to assess the safety and tolerability of tigatuzumab (CS-1008) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC).2012

    • Author(s)
      Cheng AL
    • Organizer
      ASCO 2012 Annual Meeting
    • Place of Presentation
      Chicago,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Observations of hepatocellular carcinoma (HCC) management patterns from the Global HCC BRIDGE Study: First characterization of the full study population.2012

    • Author(s)
      Park JW
    • Organizer
      ASCO 2012 Annual Meeting
    • Place of Presentation
      Chicago,USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE Study: An interim analysis of HCC burden of illness in the Asia-Pacific (AP) cohort.2012

    • Author(s)
      Orsini LS
    • Organizer
      International Society for Pharmacoeconomics and Outsomes Research (ISPOR) 5th Asia-Pacific Conference
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2012 Annual Research Report
  • [Presentation] Brivanib versus placebo in patients with advanced hepatocellular carcinoma (HCC) who failed or were intolerant to sorafenib: results from the phase III Brisk-Ps Study.2012

    • Author(s)
      Llovet JM
    • Organizer
      Sixth Annual Conference International Liver Cancer Association(ILCA)
    • Place of Presentation
      Berlin, Germany
    • Related Report
      2012 Annual Research Report
  • [Presentation] The decrease of blood flow after administration of sorafenib may improve overall survival in patients with advanced hepatocellular carcinoma.2012

    • Author(s)
      Arizumi T
    • Organizer
      Sixth Annual Conference International Liver Cancer Association(ILCA)
    • Place of Presentation
      Berlin, Germany
    • Related Report
      2012 Annual Research Report
  • [Presentation] Brivanib versus placebo in patients with advanced hepatocellular carcinoma who failed or were intolerant to sorafenib: assessment of baseline and on-treatment alpha-fetoprotein levels in the phase III Brisk-Ps study.2012

    • Author(s)
      Raoul JL
    • Organizer
      Sixth Annual Conference International Liver Cancer Association(ILCA)
    • Place of Presentation
      Berlin, Germany
    • Related Report
      2012 Annual Research Report
  • [Presentation] Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: global comprison of outcomes by staging system.2012

    • Author(s)
      Sherman M
    • Organizer
      Sixth Annual Conference International Liver Cancer Association(ILCA)
    • Place of Presentation
      Berlin
    • Related Report
      2012 Annual Research Report
  • [Presentation] Final results of a randomized Phase II study of TSU-68 after transarterial chemoembolisation in Japanese patients with unresectable hepatocellular carcinoma. Chemoembolization.2012

    • Author(s)
      Kaneko S
    • Organizer
      ESMO 2012
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2012 Annual Research Report
  • [Presentation] GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and of its treatment with soraeNib) second interim analysis: subgoup analysis by disease aetiology.2012

    • Author(s)
      Bronowicki JP
    • Organizer
      ESMO 2012
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2012 Annual Research Report
  • [Presentation] Phase I/II trial of lenvatinib (E7080), a multi-targeted tyrosine kinase inhibitor, in patients with advanced hepatocellular carcinoma (HCC).2012

    • Author(s)
      Ikeda K
    • Organizer
      ESMO 2012
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2012 Annual Research Report
  • [Presentation] Role of hepatic resection for hepatocellular carcinoma: analysis of the HCC BRIDGE study.2012

    • Author(s)
      Roayaie S
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] Efficacy and safety of miriplatin for hepatocellular carcinoma: a multi-center retrospective study in Japan.2012

    • Author(s)
      Arai K
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Sorafenib deteriorates liver function in patients with advanced hepatocellular carcinoma: a multi-center retrospective study in Japan.2012

    • Author(s)
      Sunagozaka H
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Predicting the treatment efficacy of sorafenib in patients for hepatocellular carcinoma: a multi-center retrospective study in Japan.2012

    • Author(s)
      Yamashita T
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Surgical resection for lymph node metastasis from hepatocellular carcinoma: a report of the Japanese nationwide survey.2012

    • Author(s)
      Hasegawa K
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Observations of hepatocellular carcinoma(HCC) management patterns from the global HCC BRIDGE study: global comparison of outcomes by locoregional therapy.2012

    • Author(s)
      Schwartz M
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with SoraeNib) second interim analysis: subgoup analysis by disease aetiology.2012

    • Author(s)
      Bronowicki JP
    • Organizer
      The 63th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] Feasibility study of iron density quantification in liver with single source dual energy CT with first kVp switching.2012

    • Author(s)
      Sasaki K
    • Organizer
      98th Scientific Assembly and Annual Meeting (RSNA 2012)
    • Place of Presentation
      Chicago, USA
    • Related Report
      2012 Annual Research Report
  • [Presentation] The retrospective study of novel anticancer agent, miriplatin in TACE and TAI for unresectable hepatocellular carcinoma in Japan.2012

    • Author(s)
      Nagai N
    • Organizer
      Asian Pacific Digestive Week (APDW) 2012
    • Place of Presentation
      Bangkok, Thailand
    • Related Report
      2012 Annual Research Report
  • [Presentation] “The role of TACE & Nexavar in HCC treatment.”2012

    • Author(s)
      Kudo M
    • Organizer
      HCC Expert Symposium on Tumor Therapy
    • Place of Presentation
      Seoul, Korea
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Endoscopic ultrasound in the differential diagnosis of cystic pancreatic lesions: do we always need it? ”2012

    • Author(s)
      Kudo M
    • Organizer
      EFSUMB Annual Meeting EUROSON 2012
    • Place of Presentation
      Madrid, Spain
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “CEUS as a screening tool of HCC in cirrhotic liver. ”2012

    • Author(s)
      Kudo M
    • Organizer
      ACUCI 2012, The 4th Asian Conference on Ultrasound Contrast Imaging
    • Place of Presentation
      Korea
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “CEUS in the pancreatobiliary intervention. ”2012

    • Author(s)
      Kudo M
    • Organizer
      ACUCI 2012, The 4th Asian Conference on Ultrasound Contrast Imaging
    • Place of Presentation
      Korea
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: an analysis of the Asian cohort. ” "Recent observation in the management of HCC"2012

    • Author(s)
      Kudo M
    • Organizer
      The 3rd Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)
    • Place of Presentation
      Shanghai, China
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Japanese treatment algorithm.“ Session XII ”Algorithm Consensus Discussion”2012

    • Author(s)
      Kudo M
    • Organizer
      The 3rd Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)
    • Place of Presentation
      Shanghai, China
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Management of TACE failure: Difinition on TACE failure/refractoriness”2012

    • Author(s)
      Kudo M
    • Organizer
      Expert Panel Opinion on Interventions In Hepatocellular Carcinoma (EPOIHCC)
    • Place of Presentation
      Shanghai, China
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Review of the evidence suppporting combination therapy in intermediate HCC: GIDEON”2012

    • Author(s)
      Kudo M
    • Organizer
      Expert Panel Opinion on Interventions In Hepatocellular Carcinoma (EPOIHCC)
    • Place of Presentation
      Shanghai, China
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Diagnosis by Imaging: Eastern approach”2012

    • Author(s)
      Kudo M
    • Organizer
      Program for the Advancement of Therapy in Hepatocellular Carcinoma (PATH)
    • Place of Presentation
      Shanghai, China
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Real life experience with Nexavar: GIDEON 2nd IA” “Advanced HCC: rich evidence for Nexavar”2012

    • Author(s)
      Kudo M
    • Organizer
      Advances in HCC management in Asia
    • Place of Presentation
      Ho Chi Minh , Vietnam
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Controversies on the role of TACE” “Intermediate HCC”2012

    • Author(s)
      Kudo M
    • Organizer
      Advances in HCC management in Asia
    • Place of Presentation
      Ho Chi Minh , Vietnam
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “Liver biopsy: Is it useful for staging?”2012

    • Author(s)
      Kudo M
    • Organizer
      Sixth Annual Conference International Liver Cancer Association(ILCA)
    • Place of Presentation
      Berlin, Germany
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] “HCC challenges: Definition on TACE failure and refractoriness.”2012

    • Author(s)
      Kudo M
    • Organizer
      HCC Expert Meeting and Asia Pacific Virtual Meeting -Expert discussion on HCC management-
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] CEUS, EOB-MRI, targeted therapy and Japanese HCC guideline2012

    • Author(s)
      Kudo M
    • Organizer
      Cancer Genomics: a way to personalized medicine(招待講演)
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2011 Research-status Report
  • [Presentation] Evolving strategies on the treatment of HCC: Physician’s perspective2012

    • Author(s)
      Kudo M
    • Organizer
      The 22nd conference of the Asian Pacific Association for the Study of the Liver (APASL 2012)(招待講演)
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2011 Research-status Report
  • [Presentation] Hepatocellular carcinoma2012

    • Author(s)
      Kudo M
    • Organizer
      The 22nd conference of the Asian Pacific Association for the Study of the Liver (APASL 2012)(招待講演)
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2011 Research-status Report
  • [Presentation] Real life experience with Sorafenib: GIDEON, the largest prospective global study in HCC2012

    • Author(s)
      Kudo M
    • Organizer
      The 22nd conference of the Asian Pacific Association for the Study of the Liver (APASL 2012)(招待講演)
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2011 Research-status Report
  • [Presentation] From JSH treatment guideline to combination therapy2012

    • Author(s)
      Kudo M
    • Organizer
      HCC Expert Meeting -New Advances in HCC Management(招待講演)
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2011 Research-status Report
  • [Presentation] Management of hepatocellular carcinoma: Recent progress2012

    • Author(s)
      Kudo M
    • Organizer
      The 42nd Annual Meeting of the Gastroenterological Society of Taiwan (GEST) and The 21st Annual Meeting of the Digestive Endoscopy Society of Taiwan (DEST)(招待講演)
    • Place of Presentation
      Taipei, Taiwan
    • Related Report
      2011 Research-status Report
  • [Presentation] Update on endoscopic USG: how much for imaging, needling, or therapy?2011

    • Author(s)
      Kudo M
    • Organizer
      The 42nd Annual Congress of the Korean Society of Ultrasound in Medicine (KSUM)(招待講演)
    • Place of Presentation
      Seoul, Korea
    • Related Report
      2011 Research-status Report
  • [Presentation] Sonazoid-enhanced US in the management of HCC2011

    • Author(s)
      Kudo M
    • Organizer
      The 42nd Annual Congress of the Korean Society of Ultrasound in Medicine (KSUM)(招待講演)
    • Place of Presentation
      Seoul, Korea
    • Related Report
      2011 Research-status Report
  • [Presentation] Hepatocellular carcinoma: prevention and treatment by interferon2011

    • Author(s)
      Kudo M
    • Organizer
      The Japanese Society for Interferon and Cytokine Research-The Japanese Society for Macrophage Molecular and Cell Biology (JSICR-MMCB) 2011(招待講演)
    • Place of Presentation
      Osaka, Japan
    • Related Report
      2011 Research-status Report
  • [Presentation] Sonazoid-enhanced US in the management of HCC2011

    • Author(s)
      Kudo M
    • Organizer
      XV Congress of the Latin American Federation for Ultrasound in Medicine and Biology (FLAUS)(招待講演)
    • Place of Presentation
      Asuncion, Paraguay
    • Related Report
      2011 Research-status Report
  • [Presentation] RECICL2011

    • Author(s)
      Kudo M
    • Organizer
      The 2nd Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)(招待講演)
    • Place of Presentation
      Osaka, Japan
    • Related Report
      2011 Research-status Report
  • [Presentation] EVOLVE-1 trial2011

    • Author(s)
      Kudo M
    • Organizer
      The 2nd Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)(招待講演)
    • Place of Presentation
      Osaka, Japan
    • Related Report
      2011 Research-status Report
  • [Presentation] Current situation of HCC management in Japan2011

    • Author(s)
      Kudo M
    • Organizer
      The 2nd Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)(招待講演)
    • Place of Presentation
      Osaka, Japan
    • Related Report
      2011 Research-status Report
  • [Presentation] Design and conduct of clinical trials for the design and rational of clinical trials for the combination of hepatic arterial infusion chemotherapy with molecular targeted agents2011

    • Author(s)
      Kudo M
    • Organizer
      The 2nd Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)(招待講演)
    • Place of Presentation
      Osaka, Japan
    • Related Report
      2011 Research-status Report
  • [Presentation] US-guided ablation of HCC2011

    • Author(s)
      Kudo M
    • Organizer
      13th World Congress of the world federation for ultrasound in medicine and biology (WFUMB) 2011(招待講演)
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2011 Research-status Report
  • [Presentation] Benefit and nonsense in oncologic follow-up imaging and the role of US2011

    • Author(s)
      Kudo M
    • Organizer
      13th World Congress of the world federation for ultrasound in medicine and biology (WFUMB) 2011(招待講演)
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2011 Research-status Report
  • [Presentation] Future prospects of ultrasound diagnosis for diffuse liver disease2011

    • Author(s)
      Kudo M
    • Organizer
      13th World Congress of the world federation for ultrasound in medicine and biology (WFUMB) 2011(招待講演)
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2011 Research-status Report
  • [Presentation] Establishing treatment algorithms for hepatocellular carcinoma: What tests do we need?2011

    • Author(s)
      Kudo M
    • Organizer
      19th United European Gastroenterology Week (UEGW)(招待講演)
    • Place of Presentation
      Stockholm, Sweden
    • Related Report
      2011 Research-status Report
  • [Presentation] Hepatocellular carcinoma: Recent development of molecular targeted agent2011

    • Author(s)
      Kudo M
    • Organizer
      The 49th Annual Meeting of Japan Society of Clinical Oncology(招待講演)
    • Place of Presentation
      Nagoya Congress Center, Aichi, Japan
    • Related Report
      2011 Research-status Report
  • [Presentation] Interventional EUS for pancreatobiliary tumors2011

    • Author(s)
      Kudo M
    • Organizer
      9th ABDA teaching course in conjunction with AFSUMB Workshop(招待講演)
    • Place of Presentation
      Bali, Indonesia
    • Related Report
      2011 Research-status Report
  • [Presentation] Sonazoid-enhanced US in the management of HCC2011

    • Author(s)
      Kudo M
    • Organizer
      9th ABDA teaching course in conjunction with AFSUMB Workshop(招待講演)
    • Place of Presentation
      Bali, Indonesia
    • Related Report
      2011 Research-status Report
  • [Presentation] Clinical staging systems for HCC2011

    • Author(s)
      Kudo M
    • Organizer
      APASL 2nd Hepatocellular carcinoma conference (APASL STC)(招待講演)
    • Place of Presentation
      Jeju, Korea
    • Related Report
      2011 Research-status Report
  • [Presentation] Diagnosis of gross pathology of HCC: Value of Kupffer phase of Sonazoid-enhanced US2011

    • Author(s)
      Kudo M
    • Organizer
      3rd Asia-Pacific Conference on Ultrasound Contrast Imaging, 13th International Symposium on Ultrasound Contrast Imaging(招待講演)
    • Place of Presentation
      Kunming, China
    • Related Report
      2011 Research-status Report
  • [Presentation] Molecular targeting therapy2011

    • Author(s)
      Kudo M
    • Organizer
      The 7th APASL single topic conference(招待講演)
    • Place of Presentation
      Makuhari Messe, Chiba, Japan
    • Related Report
      2011 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi